Thyroid carcinoma

Steven I. Sherman*, Peter Angelos, Douglas W. Ball, David Byrd, Orlo H. Clark, Gilbert H. Daniels, Raza A. Dilawari, Hormoz Ehya, William B. Farrar, Robert F. Gagel, Fouad Kandeel, Richard T. Kloos, Peter Kopp, Dominick M. Lamonica, Thorn R. Loree, William M. Lydiatt, Judith McCaffrey, John A. Olson, John A. Ridge, Jatin P. ShahJames C. Sisson, R. Michael Tuttle, Marshall M. Urist

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

51 Scopus citations


Although thyroid carcinoma is relatively uncommon, approximately 33,550 new cases will be diagnosed in the United States in 2007. It occurs 2 to 3 times more often in women than in men, and with the incidence increasing by 4% per year, it is currently the eighth most common malignancy diagnosed in women. Although it occurs more often in women, mortality rates are higher for men, probably because they are usually older at the time of diagnosis (65-69 years vs. 50-54 years in women). Interestingly, the incidence of thyroid carcinoma increased almost 240% between 1950 and 2000, but mortality rates decreased more than 44%. Important updates to the 2007 guidelines include revised criteria for categorizing disease, revised recommendation for thyroid-stimulating hormone-stimulated thyroglobulin in some cases, and expanded CT recommendations for anaplastic carcinoma.

Original languageEnglish (US)
Pages (from-to)568-621
Number of pages54
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number6
StatePublished - Jul 2007
Externally publishedYes


  • Anaplastic thyroid cancer
  • Cancer
  • Follicular cancer
  • Hürthle cell carcinoma
  • Malignancy
  • Medullary thyroid cancer
  • NCCN Clinical Practice Guidelines
  • Papillary thyroid cancer
  • Radioactive iodine
  • Thyroid gland
  • Thyroidectomy
  • Tumor

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Thyroid carcinoma'. Together they form a unique fingerprint.

Cite this